Penn Davis Mcfarland Inc Bristol Myers Squibb CO Transaction History
Penn Davis Mcfarland Inc
- $953 Million
- Q3 2025
A detailed history of Penn Davis Mcfarland Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Penn Davis Mcfarland Inc holds 351,657 shares of BMY stock, worth $16 Million. This represents 1.66% of its overall portfolio holdings.
Number of Shares
351,657
Previous 356,610
1.39%
Holding current value
$16 Million
Previous $16.5 Million
3.93%
% of portfolio
1.66%
Previous 1.89%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.89 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.24 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.93 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.32 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.23 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...